Robuta

https://medbiosci.ru/MedBiotech/article/view/283264
Evaluation of the Effectiveness of Benralizumab in a Patient with Severe Bronchial Asthma
in aevaluationeffectivenessbenralizumabpatient
https://www.cochrane.org/es/evidence/CD010834_mepolizumab-reslizumab-or-benralizumab-people-already-taking-inhaled-steroids-and-long-acting-beta-2
mepolizumabreslizumabbenralizumabparapersonas
https://www.ajmc.com/view/fda-approves-benralizumab-for-eosinophilic-granulomatosis-with-polyangiitis
The FDA approved benralizumab (Fasenra) for adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).
fdabenralizumabeosinophilicgranulomatosispolyangiitis
https://www.elsevier.es/en-revista-acta-otorrinolaringologica-espanola-402-articulo-real-life-outcomes-benralizumab-treatment-in-S2173573525000894
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type 2 inflammatory disease with a
real lifechronic rhinosinusitisoutcomesbenralizumabtreatment